Prescott Group Capital Management, L.L.C. Standard Biotools Inc. Transaction History

Prescott Group Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.8 - $3.96 $149,060 - $210,814	-53,236 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.63 - $6.13 $193,246 - $326,336	53,236 New	53,236 $209,000
Q4 2020 Feb 10, 2021	SELL	$5.45 - $8.65 $528,650 - $839,050	-97,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.34 - $11.43 $420,980 - $1.11 Million	97,000 New	97,000 $721,000
Q3 2019 Nov 13, 2019	SELL	$4.63 - $12.15 $212,980 - $558,900	-46,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$8.47 - $14.36 $389,620 - $660,560	46,000 New	46,000 $611,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Prescott Group Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Prescott Group Capital Management, L.L.C. with notifications on news.